Trade Summary

Yesterday, CARDOZA GEORGE, serving as Chief Financial Officer at SOPHiA GENETICS SA (SOPH), purchased 20,000 shares at $4.95 per share, for a total transaction value of $99,000.00. Following this transaction, CARDOZA GEORGE now holds 311,458 shares of SOPH.

This purchase represents a 6.86% increase in CARDOZA GEORGE's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 5, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 5, 2026 at 4:02 PM ET, meaning the disclosure happened on the same day as the trade.

SOPHiA GENETICS SA operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.